CV Quality Corner

Clinical data registry programs like ACC’s NCDR “provide unique opportunities to advance the understanding of the clinical characteristics, care and outcomes of patients with cardiovascular disease,” according to the recent “Trends in U.S. Cardiovascular Care” report.

The report, published in the Journal of the American College of Cardiology (JACC), provides insights based on 2014 data into the patient populations, participating centers and patterns of care from four of the 10 NCDR registries – CathPCI Registry, ICD Registry, ACTION Registry-GWTG and IMPACT Registry. These registry programs focus on PCI interventions, implantable cardioverter-defibrillator (ICD) implantation, acute coronary treatment and outcomes and pediatric and adult congenital heart disease.

Key findings from each registry include:

CathPCI Registry

Of the 667,424 patients undergoing PCI in 2014, 35.3 percent of PCIs were performed for elective indications, compared with 64.7 percent performed for non-elective indications.

Between 2011 and 2014, the use of femoral access declined from 88.4 percent to 74.5 percent, while the use of radial access increased from 10.9 percent to 25.2 percent.

Use of evidence-based therapies, including aspirin, P2Y12 inhibitors and statins for eligible patients, continue to remain high at 93.3 percent.

Median door-to-balloon time for primary PCI for STEMI also remains strong at 59 minutes for patients receiving PCI at the presenting hospital and 105 minutes for transfer patients.

Cardiology

Clinical Topics: Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Implantable Devices, SCD/Ventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Quality Improvement

Keywords: ACC Publications, Cardiology Magazine, Cardiovascular Diseases, Defibrillators, Implantable, Heart Defects, Congenital, Registries


< Back to Listings